These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2159667)
1. [Aminobenzoic acid derivatives as specific inhibitors of cyclic nucleotide phosphodiesterase in the rat uterus]. Garnovskaia MN; Tret'iakov AV; Maslova MN; Etingof RN Ukr Biokhim Zh (1978); 1990; 62(1):97-101. PubMed ID: 2159667 [TBL] [Abstract][Full Text] [Related]
2. [Participation of the estradiol receptor in the hormonal inhibition of cyclic nucleotide phosphodiesterase in the uterus]. Garnovskaia MN; Dumler IL Ukr Biokhim Zh (1978); 1984; 56(6):633-7. PubMed ID: 6096994 [TBL] [Abstract][Full Text] [Related]
3. [Role of cyclic nucleotide phosphodiesterase in the effect of estradiol on uterine tissue]. Garnovskaia MN; Dumler IL; Etingof RN Biull Eksp Biol Med; 1982 Jun; 93(6):110-2. PubMed ID: 6288142 [TBL] [Abstract][Full Text] [Related]
4. [Peptide-activator of cyclic nucleotide phosphodiesterases in the rat and human uterus]. Garnovskaia MN; Savitskiĭ GA Ukr Biokhim Zh (1978); 1989; 61(4):100-3. PubMed ID: 2555944 [TBL] [Abstract][Full Text] [Related]
5. [Effect of estradiol on 3',5'-AMP-phosphodiesterase activity in rat uterus. Participation of hormone receptors, the role of guanyl nucleotides]. Etingof RN; Garnovskaia MN; Usova AA; Dumler IL Ukr Biokhim Zh (1978); 1983; 55(1):53-7. PubMed ID: 6298983 [TBL] [Abstract][Full Text] [Related]
7. [Protein inhibitor of cyclic nucleotide phosphodiesterase in the retina in hereditary degeneration]. Usova AA; Ostapenko IA; Etingof RN Vopr Med Khim; 1978; 24(2):227-32. PubMed ID: 27006 [TBL] [Abstract][Full Text] [Related]
8. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. Kauffman RF; Schenck KW; Utterback BG; Crowe VG; Cohen ML J Pharmacol Exp Ther; 1987 Sep; 242(3):864-72. PubMed ID: 2821228 [TBL] [Abstract][Full Text] [Related]
9. [Influence of effectors of hormone-sensitive adenylate cyclase on the activation system of photostimulated cyclic nucleotide phosphodiesterase from outer rod segments]. Kalinina SN; Etingof RN Ukr Biokhim Zh (1978); 1986; 58(2):34-41. PubMed ID: 3010521 [TBL] [Abstract][Full Text] [Related]
10. [Participation of the adenyl cyclase system in estradiol-activated growth of tumors in rat mammary glands]. Nagibneva IN; Morozova TM; Merkulova TI; Protopopova MV Biokhimiia; 1985 Feb; 50(2):231-6. PubMed ID: 2985126 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthma. Silver PJ; Gordon RJ; Buchholz RA; Dundore RL; Ferguson EW; Harris AL; Pagani ED Adv Second Messenger Phosphoprotein Res; 1992; 25():341-51. PubMed ID: 1313266 [No Abstract] [Full Text] [Related]
12. Comparative structure-activity relationships for dihydropyridines as inhibitors of [3H]-nitrendipine binding vs cyclic nucleotide phosphodiesterases. Van Inwegen RG; Weinryb I; Jones H; Khandwala A Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):191-206. PubMed ID: 6091198 [TBL] [Abstract][Full Text] [Related]
13. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships. Wu PH; Phillis JW; Nye MJ Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531 [No Abstract] [Full Text] [Related]
14. [The action of émoksipin on the basal activity of cyclic nucleotide phosphodiesterase and on the late receptor potential of the isolated retina]. Shvedova AA; Polianskiĭ NB; Akopian GKh; Dzhafarov AI Biull Eksp Biol Med; 1989 Sep; 108(9):289-91. PubMed ID: 2558741 [TBL] [Abstract][Full Text] [Related]
15. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. Levin RM; Weiss B Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095 [No Abstract] [Full Text] [Related]
16. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Drees M; Zimmermann R; Eisenbrand G Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385 [TBL] [Abstract][Full Text] [Related]
17. [Properties of cyclic nucleotide phosphodiesterase from plasma membranes of rat synaptosomes at early stages of acute radiation injury]. Parkhomets TI; Vasil'ev AN; Kucherenko NE Ukr Biokhim Zh (1978); 1988; 60(3):25-30. PubMed ID: 2842904 [TBL] [Abstract][Full Text] [Related]
18. [Changes in the proteins of the outer segments of retinal rods in rats with tapeto-retinal dystrophies]. Etingof RN; Ostapenko IA Vestn Akad Med Nauk SSSR; 1978; (10):3-8. PubMed ID: 212898 [No Abstract] [Full Text] [Related]
19. KS-501 and KS-502, new inhibitors of Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Sporothrix sp. Nakanishi S; Ando K; Kawamoto I; Kase H J Antibiot (Tokyo); 1989 Jul; 42(7):1049-55. PubMed ID: 2546910 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the cardiac membrane-bound cyclic nucleotide phosphodiesterase: inhibition due to a contamination of TLC purified S-adenosyl-L-[methyl-3H] methionine by Zn++ ions. Dubois M; Prigent AF; Némoz G; Fougier S; Pacheco H Life Sci; 1985 Jul; 37(4):315-24. PubMed ID: 2989649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]